Sarcoidosis clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Vitamin D Homeostasis in Sarcoidosis
- Virtual Patient Groups for Sarcoidosis Associated Fatigue
- Feasibility of Semaglutide in Advanced Lung Disease
- Cell Free DNA in Cardiac Sarcoidosis
- Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- Risk Indicators of Sarcoidosis Evolution-Unified Protocol
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
- Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
- Cardiovascular Multimodality Imaging Study
- Interstitial Lung Disease Research Unit Biobank
- Rheumatology Patient Registry and Biorepository
- Mayo AVC Registry and Biobank
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
- Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- University of Virginia Natural History Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Sarcoidosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.